Category: FDA

We have great news for those of you suffering from allergy-related sinus pain. The FDA just approved the first over-the-counter (OTC) medical device for sinus pain, ClearUP. Here’s what you need to know about the new device. How does ClearUP work? The ClearUP device is the first of its kind, treating sinus pain through electrical… Read More

After a long wait, generic Latuda (lurasidone), used to treat schizophrenia and bipolar disorder, has been approved by the FDA and should be available in pharmacies soon, according to manufacturer Lupin Pharmaceuticals. The cash price for a 30-day supply of brand-name is around $1,500. Lurasidone’s release could be a reprieve for patients struggling to afford… Read More

The FDA just approved a new drug for Parkinson’s disease, a nervous system disorder that affects movement and causes tremors, muscle stiffness, and problems with speech, walking, and writing. The current drug of choice for Parkinson’s disease is the combination medication, , but unfortunately, it comes with some limitations. Patients with Parkinson’s taking carbidopa/levodopa experience… Read More

Prescription fill rates for fluoroquinolone antibiotics have dropped nearly 40% since January 2014, according to a new GoodRx analysis. It’s been a decade since the FDA made the first of six increasingly severe safety warnings about these effective, but risky, medications. Used for more than 30 years, fluoroquinolones are approved to treat certain serious bacterial… Read More

Teva Pharmaceuticals recently announced that the FDA approved ProAir Digihaler, the first and only dry powder digital rescue inhaler used to treat asthma and COPD. While this is a big step for inhalers, Digihaler likely won’t be available for at least another year. How does ProAir Digihaler work? ProAir Digihaler is a rescue inhaler containing… Read More

Emergency contraception (Plan B or the morning-after pill) has changed so much in the past few decades, it can be difficult to know where things stand. There are more options than ever before to prevent pregnancy after birth control failure or unprotected sex, and many are now available over the counter.     To get… Read More

Last month, Celltrion Healthcare received FDA approval for Truxima, the first biosimilar for Rituxan, to treat non-Hodgkin’s lymphoma. Truxima is the fifteenth biosimilar approved in the United States, and will be available at a reduced cost compared to the expensive reference product Rituxan.     What is a biosimilar? A biosimilar is technically the “generic”… Read More

For a large portion of Americans, a simple bee sting or a peanut can cause a fatal allergic reaction called anaphylaxis. Fortunately, in most cases, these symptoms can be treated by a shot to the leg with an epinephrine auto-injector. Unfortunately, one of the most popular auto-injectors,  , costs around $630 for a pack of… Read More

Approved in 2010, Gilenya is used to treat multiple sclerosis (MS), but a new safety announcement reveals that Gilenya may lead to potentially disabling side effects, even after the drug is stopped. According to the FDA, discontinuing Gilenya can result in severe worsening of MS that could lead to disability. Are you currently taking Gilenya?… Read More

Jetsetters hit with the E. coli infection, known as traveler’s diarrhea, have a new treatment option. Aemcolo, approved by the FDA on November 16th, 2018, is the first drug in 10 years approved for traveler’s diarrhea and gives patients an alternative to the typically prescribed broad-spectrum antibiotics like ciprofloxacin and Xifaxan. What is Aemcolo for?… Read More